- Zacks via Yahoo FinanceSep 19 15:32 PM
Johnson & Johnson JNJ announced that the FDA has granted approval to its new prostate cancer drug Erleada for an expanded patient population. With the latest approval, Erleada can now be prescribed ...
- Market Watch1 day ago
- Investing.com3 days ago
... Inc. (China), Glenmark (India), Impax Laboratories, LLC (US), Mylan N.V. (US), Teva Pharmaceuticals Industries...Market Watch2 days ago
- related to Mylan Laboratories Ltd